Business News • MarketWire • INVO Bioscience Announces the Signing of Distribution Company Delfran Pharmaceuticals and First INVO Babies Born in Colombia |
INVO Bioscience Announces the Signing of Distribution Company Delfran Pharmaceuticals and First INVO Babies Born in Colombia |
|
|
INVO Bioscience Announces the Signing of Distribution Company Delfran Pharmaceuticals and First INVO Babies Born in Colombia
BEVERLY, MA--(Marketwire - February 23, 2010) - INVO Bioscience, Inc. (OTCBB: IVOB), a medical device company focused on treatment options for patients diagnosed with infertility, announced today the signing of an agreement with a South African distribution company Delfran Pharmaceuticals (http://www.delfran.co.za/). Delfran is a drug and medical device distribution company that is looking to bring the low cost INVO procedure into African nations, making infertility treatment affordable to the general public. CEO Katie Karloff stated, "The shortage of a cost effective treatment has left assistance for many couples simply out of reach. We believe that INVO Bioscience partnered with Delfran can bring an affordable infertility procedure to couples in many areas of Africa."
View More : http://www.marketwire.com/mw/release.do?id=1120674&sourceType=3
|
|
|